Peter Bantock
Plus aucun poste en cours
Historique de carrière de Peter Bantock
Anciens postes connus de Peter Bantock
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | 01/01/2011 | 01/10/2012 |
| ACCELERATE DIAGNOSTICS, INC. | Responsable des Ressources Humaines | 01/04/2015 | - |
| Corporate Officer/Principal | - | - |
Formation de Peter Bantock
| Rhodes University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Afrique du Sud | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Human Resources Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACCELERATE DIAGNOSTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
- Bourse
- Insiders
- Peter Bantock
- Expérience
